{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:06:41Z","timestamp":1780733201872,"version":"3.54.1"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0131242","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T18:23:33Z","timestamp":1435170213000},"page":"e0131242","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid Tumors"],"prefix":"10.1371","volume":"10","author":[{"given":"Siri","family":"T\u00e4htinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saija","family":"Kaikkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiju","family":"Merisalo-Soikkeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Gr\u00f6nberg-V\u00e4h\u00e4-Koskela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kanerva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvi","family":"Parviainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"V\u00e4h\u00e4-Koskela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akseli","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"issue":"13","key":"ref1","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"SA Rosenberg","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"32","key":"ref2","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1200\/JCO.2008.16.5449","article-title":"Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens","volume":"26","author":"ME Dudley","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","article-title":"Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma","volume":"23","author":"ME Dudley","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fimmu.2013.00363","article-title":"TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu","volume":"4","author":"A Kunert","year":"2013","journal-title":"Front Immunol"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molmed.2012.04.009","article-title":"CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe","volume":"18","author":"DE Gilham","year":"2012","journal-title":"Trends Mol Med"},{"issue":"95","key":"ref6","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"M Kalos","year":"2011","journal-title":"Sci Transl Med"},{"issue":"16","key":"ref7","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia","volume":"371","author":"SL Maude","year":"2014","journal-title":"N Engl J Med"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1158\/1078-0432.CCR-13-2627","article-title":"Multifactorial T cell Hypofunction That is Reversible Can Limit the Efficacy of Chimeric Antibody Receptor-transduced Human T cells in Solid Tumors","volume":"20","author":"EK Moon","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"e24850","DOI":"10.4161\/onci.24850","article-title":"Trial Watch: Immunostimulatory cytokines","volume":"2","author":"E Vacchelli","year":"2013","journal-title":"Oncoimmunology"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrc2843","article-title":"The colony-stimulating factors and cancer","volume":"10","author":"D Metcalf","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"ref11","first-page":"661","article-title":"Interferons alpha and beta as immune regulators\u2014a new look Immunity","volume":"14","author":"CA Biron","year":"2001","journal-title":"Interferons alpha and beta as immune regulators\u2014a new look Immunity"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4161\/onci.20459","article-title":"Trial Watch: Immunostimulatory cytokines","volume":"1","author":"E Vacchelli","year":"2012","journal-title":"Oncoimmunology"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1634\/theoncologist.11-4-397","article-title":"TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility","volume":"11","author":"R van Horssen","year":"2006","journal-title":"Oncologist"},{"issue":"11 Pt 1","key":"ref14","first-page":"4420","article-title":"Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor","volume":"41","author":"MT Lotze","year":"1981","journal-title":"Cancer Res"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/cbr.2012.1220","article-title":"Should high-dose interleukin-2 still be the preferred treatment for patients with metastatic melanoma?","volume":"27","author":"RO Dillman","year":"2012","journal-title":"Cancer Biother Radiopharm"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.3390\/cancers3043856","article-title":"Cytokines in cancer immunotherapy","volume":"3","author":"S Lee","year":"2011","journal-title":"Cancers (Basel)"},{"issue":"19","key":"ref17","first-page":"5495","article-title":"Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion","volume":"62","author":"E Linardakis","year":"2002","journal-title":"Cancer Res"},{"issue":"9 pt.1","key":"ref18","first-page":"3160","article-title":"Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity","volume":"36","author":"IJ Fidler","year":"1976","journal-title":"Cancer Res"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.cji.0000203078.97493.c3","article-title":"Accumulation in tumor tissue of adoptively transferred T cells: A comparison between intravenous and intraperitoneal injection","volume":"29","author":"CC Petersen","year":"2006","journal-title":"J Immunother"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: the first effective immunotherapy for human cancer","volume":"192","author":"SA Rosenberg","year":"2014","journal-title":"J Immunol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3626","article-title":"The secret ally: immunostimulation by anticancer drugs","volume":"11","author":"L Galluzzi","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fonc.2013.00128","article-title":"Radiotherapy effects on anti-tumor immunity: implications for cancer treatment","volume":"3","author":"S Demaria","year":"2013","journal-title":"Front Oncol"},{"issue":"21","key":"ref23","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1158\/0008-5472.CAN-03-3301","article-title":"Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells","volume":"64","author":"E Obermueller","year":"2004","journal-title":"Cancer Res"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/ijc.26447","article-title":"Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants","volume":"131","author":"KM Kaluza","year":"2012","journal-title":"Int J Cancer"},{"issue":"2","key":"ref25","first-page":"182","article-title":"Tumor-induced perturbations of cytokines and immune cell networks","volume":"1845","author":"B Burkholder","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.4049\/jimmunol.181.12.8576","article-title":"IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17","volume":"181","author":"CJ Henry","year":"2008","journal-title":"J Immunol"},{"issue":"21","key":"ref27","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.1158\/0008-5472.CAN-09-1627","article-title":"Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosis","volume":"69","author":"C Domschke","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI74894","article-title":"Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis","volume":"125","author":"C Reissfelder","year":"2015","journal-title":"J Clin Invest"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jnci\/90.4.287","article-title":"Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas","volume":"90","author":"E Tartour","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/blood-2005-06-2399","article-title":"IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients","volume":"107","author":"M Ahmadzadeh","year":"2006","journal-title":"Blood"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1200\/JCO.2004.10.041","article-title":"Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance","volume":"22","author":"MY Mapara","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"A Sica","year":"2012","journal-title":"J Clin Invest"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1189\/jlb.1006640","article-title":"Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion","volume":"81","author":"TA Dietlin","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"e23564","DOI":"10.4161\/onci.23564","article-title":"Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumors","volume":"2","author":"P Spear","year":"2013","journal-title":"Oncoimmunology"},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.4049\/jimmunol.175.7.4797","article-title":"Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells","volume":"175","author":"V Vignard","year":"2005","journal-title":"J Immunol"},{"issue":"27","key":"ref36","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1073\/pnas.0503726102","article-title":"Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells","volume":"102","author":"CA Klebanoff","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.4049\/jimmunol.171.10.5051","article-title":"IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2","volume":"171","author":"C Jackaman","year":"2003","journal-title":"J Immunol"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.cgt.7700475","article-title":"Immunotherapy for murine K1735 melanoma: combinatorial use of recombinant adenovirus expressing CD40L and other immunomodulators","volume":"9","author":"I Peter","year":"2002","journal-title":"Cancer Gene Ther"},{"issue":"19","key":"ref39","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1158\/1078-0432.CCR-13-0143","article-title":"CTLA-4 and PD-1\/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients","volume":"19","author":"PA Ott","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"7395","key":"ref40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10975","article-title":"Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'","volume":"484","author":"AM Levin","year":"2012","journal-title":"Nature"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4049\/jimmunol.1202088","article-title":"Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8\/A9 proinflammatory proteins","volume":"190","author":"L Wang","year":"2013","journal-title":"J Immunol"},{"issue":"12","key":"ref42","doi-asserted-by":"crossref","first-page":"e50946","DOI":"10.1371\/journal.pone.0050946","article-title":"Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature","volume":"7","author":"MO Hoque","year":"2012","journal-title":"PLoS ONE"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.4049\/jimmunol.162.10.5728","article-title":"Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation","volume":"162","author":"V Bronte","year":"1999","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2051-1426-1-8","article-title":"A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)\/montanide\/GM-CSF-vaccine in patients with pancreatic adenocarcinoma","volume":"1","author":"DM Geynisman","year":"2013","journal-title":"J Immunother Cancer"},{"issue":"8","key":"ref45","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1200\/JCO.2000.18.8.1614","article-title":"Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor","volume":"18","author":"LE Spitler","year":"2000","journal-title":"J Clin Oncol"},{"issue":"20","key":"ref46","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1038\/sj.onc.1206459","article-title":"GM-CSF-secreting melanoma vaccines","volume":"22","author":"G Dranoff","year":"2003","journal-title":"Oncogene"},{"issue":"22","key":"ref47","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1158\/1078-0432.CCR-06-0759","article-title":"A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor","volume":"12","author":"JC Hu","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"11","key":"ref48","first-page":"4297","article-title":"Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients","volume":"70","author":"V Cerullo","year":"2010","journal-title":"Cancer Res 2010"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.immunol.14.1.233","article-title":"CD28\/B7 system of T cell costimulation","volume":"14","author":"DJ Lenschow","year":"1996","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-5699(96)10075-X","article-title":"Implications for immunosurveillance of altered HLA class I phenotypes in human tumours","volume":"18","author":"F Garrido","year":"1997","journal-title":"Immunol Today"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/mt.2011.1","article-title":"CARs on track in the clinic","volume":"19","author":"DB Kohn","year":"2011","journal-title":"Mol Ther"},{"issue":"6055","key":"ref52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/319675a0","article-title":"Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy","volume":"319","author":"K Karre","year":"1986","journal-title":"Nature"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"DF Quail","year":"2013","journal-title":"Nat Med"},{"issue":"10","key":"ref54","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"TF Gajewski","year":"2013","journal-title":"Nat Immunol"},{"issue":"4","key":"ref55","first-page":"561","article-title":"Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses Immunity","volume":"19","author":"R Mocikat","year":"2003","journal-title":"Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses Immunity"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.4049\/jimmunol.175.4.2071","article-title":"Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells","volume":"175","author":"LA Pozzi","year":"2005","journal-title":"J Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/B978-0-12-398342-8.00008-2","article-title":"Chapter eight\u2014Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans","volume":"115","author":"V Cerullo","year":"2012","journal-title":"Adv Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0131242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T19:27:59Z","timestamp":1691782079000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0131242"}},"subtitle":[],"editor":[{"given":"Hiroshi","family":"Shiku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0131242","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,24]]}}}